1-(4-fluorobenzyl)-1H-indole-2-carboxylic acid | 406728-81-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1-(4-fluorobenzyl)-1H-indole-2-carboxylic acid
• 英文别名: 1-[(4-fluorophenyl)methyl]indole-2-carboxylic acid
• CAS: 406728-81-2
• 化学式: C₁₆H₁₂FNO₂
• 分子量: 269.275
• InChiKey: FRQAURPMQISXRG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(4-fluorobenzyl)-1H-indole-2-carboxylic acid 在 溶剂黄146 草酰氯 、 sodium cyanoborohydride 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 乙醇 、 二氯甲烷 、 二甲基亚砜 、 N,N-二甲基甲酰胺 为溶剂， 反应 38.5h， 生成 (4-((benzyl(methyl)amino)methyl)piperidin-1-yl)(1-(4-fluorobenzyl)-1H-indol-2-yl)methanone
  参考文献：
  名称：

  ARBOVIRUS INHIBITORS AND USES THEREOF

  摘要：

  本发明涉及化学化合物、其发现方法以及其治疗用途。具体而言，本发明提供了作为虫媒病毒抑制剂的化合物。

  公开号：

  US20120252807A1
• 作为产物：
  描述：

  吲哚-2-羧酸甲酯 在 水 、 sodium hydride 、 N,N-二甲基甲酰胺 、 sodium hydroxide 作用下， 以 甲醇 为溶剂， 反应 2.0h， 生成 1-(4-fluorobenzyl)-1H-indole-2-carboxylic acid
  参考文献：
  名称：

  用于治疗炎症的双靶点 COX-2/5-LOX 抑制剂的设计、合成和生物学评价

  摘要：

  花生四烯酸代谢酶环氧合酶-2（COX-2）和5-脂氧合酶（5-LOX）被认为与包括炎症在内的多种疾病的发生和发展有关。与经典的 NSAIDs 相比，双重 COX-2/5-LOX 抑制是设计具有更有效生物活性、更少副作用和更广泛抗炎谱的化合物的有效策略。在这项研究中，我们设计并合成了一系列新型吲哚和吲唑芳基酰胺苯甲酸类似物作为双重 COX-2 / 5-LOX 抑制剂，并评估了它们的体内抗炎特性。化合物7f和7n在二甲苯诱导的耳水肿小鼠模型中显示出显着的抗炎活性。此外，7f和7n在体外表现出比塞来昔布 (IC 50 = 10.04 nM)适度的 COX-2 抑制活性 (IC 50  = 537 和 321.5 nM)  ，其中7n具有更高的 COX-2 选择性活性 (选择性指数 (COX-1/COX- 2) = 7.89) 和中度 5-LOX 抑制活性 (IC 50  = 222.1 nM)。与齐留通

  DOI：

  10.1007/s00044-022-02995-8

文献信息

• Arbovirus inhibitors and uses thereof
  申请人：Larsen Scott

  公开号：US08846684B2

  公开（公告）日：2014-09-30

  The present invention relates to chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides compounds as inhibitors of arboviruses.

  本发明涉及化学化合物，其发现方法以及它们的治疗用途。特别是，本发明提供了作为蚊媒病毒抑制剂的化合物。
• Design and synthesis of novel indole and indazole-piperazine pyrimidine derivatives with anti-inflammatory and neuroprotective activities for ischemic stroke treatment
  作者：Hongwei Wang、Enjing Cui、Jiaming Li、Xiaodong Ma、Xueyang Jiang、Shuaishuai Du、Shihu Qian、Le Du

  DOI：10.1016/j.ejmech.2022.114597

  日期：2022.11

  Microglia-mediated neuroinflammation plays an important role in ischemic stroke (IS). In this work, a series of novel indole and indazole-piperazine pyrimidine derivatives with anti-neuroinflammatory and neuroprotective activities were designed and synthesized for treatment of IS. Among these compounds, 5j displayed the most attractive cytoprotective effect against oxygen-glucose deprivation/reoxygenation

  小胶质细胞介导的神经炎症在缺血性中风 (IS) 中起重要作用。在这项工作中，设计并合成了一系列具有抗神经炎症和神经保护活性的新型吲哚和吲唑-哌嗪嘧啶衍生物，用于治疗 IS。在这些化合物中，5j对 BV2 细胞中的氧 - 葡萄糖剥夺/复氧 (OGD/R) 诱导的损伤表现出最有吸引力的细胞保护作用。同时，它显着改善了炎症介质的释放，包括肿瘤坏死因子-α（TNF-α）、白细胞介素-1β（IL-1β）、IL-6、一氧化氮（NO）和前列腺素E2（PGE2）从脂多糖中的释放。 (LPS) 诱导的 BV2 细胞。此外，5j可减少 TNF-α 和 IL-1β 的释放，形成 LPS 诱导的小鼠脑神经炎症模型。作为 cyclooxygenase-2 (COX-2, IC 50  = 92.54 nM) 和 5-lipoxygenase (5-LOX, IC 50 = 41.86 nM) 的有效抑制剂 ，5j抑制小胶质细胞的
• 10.1021/acs.orglett.4c01050
  作者：Lv, Lijie、Zheng, Jia、Xiao, Yijie、Ni, Dan、Luo, Zhangshun、Gao, Yunyun、Wei, Yue、He, Yi、Nie, Shenyou

  DOI：10.1021/acs.orglett.4c01050

  日期：——

  An unusual rhodium-catalyzed C–H activation/Lossen rearrangement/oxa-Michael addition tandem cyclization has been achieved along with a tunable well-known C–H activation/[4 + 2] annulation, leading to regio-, chemo-, and diastereoselective access to diverse pentacyclic α-carbolines and β-carboline-1-one derivatives in moderate to good yields with significant anticancer activity.

  已经实现了一种不寻常的铑催化的 C–H 活化/Lossen 重排/oxa-Michael 加成串联环化以及众所周知的可调 C–H 活化/[4 + 2] 环化，从而导致区域-、化学-和非对映选择性获得多种五环α-咔啉和β-咔啉-1-酮衍生物，产率中等至良好，具有显着的抗癌活性。
• Identification of indole scaffold-based dual inhibitors of NOD1 and NOD2
  作者：Kaja Keček Plešec、Dunja Urbančič、Martina Gobec、Aleksandra Pekošak、Tihomir Tomašič、Marko Anderluh、Irena Mlinarič-Raščan、Žiga Jakopin

  DOI：10.1016/j.bmc.2016.08.044

  日期：2016.11

  NOD1 and NOD2 are important members of the pattern recognition receptor family and play a crucial role within the context of innate immunity. However, overactivation of NODs, especially of NOD1, has also been implicated in a number of diseases. Surprisingly, NOD1 remains a virtually unexploited target in this respect. To gain additional insight into the structure-activity relationships of NOD1 inhibitors, a series of novel analogs has been designed and synthesized and then screened for their NOD1-inhibitory activity. Selected compounds were also investigated for their NOD2-inhibitory activity. Two compounds 4 and 15, were identified as potent mixed inhibitors of NOD1 and NOD2, displaying a balanced inhibitory activity on both targets in the low micromolar range. The results obtained have enabled a deeper understanding of the structural requirements for NOD1 and NOD2 inhibition. (C) 2016 Elsevier Ltd. All rights reserved.
• Novel Inhibitors of Neurotropic Alphavirus Replication That Improve Host Survival in a Mouse Model of Acute Viral Encephalitis
  作者：Janice A. Sindac、Bryan D. Yestrepsky、Scott J. Barraza、Kyle L. Bolduc、Pennelope K. Blakely、Richard F. Keep、David N. Irani、David J. Miller、Scott D. Larsen

  DOI：10.1021/jm300214e

  日期：2012.4.12

  Arboviral encephalitis is a potentially devastating human disease with no approved therapies that target virus replication. We previously discovered a novel class of thieno[3,2-b]pyrrole-based inhibitors active against neurotropic alphaviruses such as western equine encephalitis virus (WEEV) in cultured cells. In this report, we describe initial development of these novel antiviral compounds, including bioisosteric replacement of the 4H-thieno[3,2-b]pyrrole core with indole to improve metabolic stability and the introduction of chirality to assess target enantioselectivity. Selected modifications enhanced antiviral activity while maintaining low cytotoidcity, increased stability to microsomal metabolism, and also revealed striking enantiospecific activity in cultured cells. Furthermore, we demonstrate improved outcomes (both symptoms and survival) following treatment with indole analogue 9h (CCG-203926) in an in vivo mouse model of alphaviral encephalitis that closely correlate with the enantiospecific in vitro antiviral activity. These results represent a substantial advancement in the early preclinical development of a promising class of novel antiviral drugs against virulent neurotropic alphaviruses.